Fig. 5From: Evaluating in vivo efficacy – toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cellsIn vivo reconstitution of healthy human hematopoietic compartments in tissues. Comparable profile between TEG001 and TEG-LM1 mock group of reconstituted healthy human hematopoietic cellular subsets in spleen and bone marrow, including total human CD45+ leukocytes (a), CD14+ monocytes (b), B cells (c), T cells (d) and CD34+ progenitor cells (e) as measured by flow cytometry. Shown in the data from individual mouse (represented by different symbols) of both TEG001 (filled symbol) and TEG-LM1 mock (open symbol) group (n = 3 mice/group)Back to article page